Related Experiment Video

Updated: Apr 16, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

13.1K

[Development of new therapies targeting human papillomavirus molecules]

Kei Kawana1

  • 1Associate Professor Department of Obstetrics and Gynecology, Graduate School of Medicine.

Uirusu
|March 14, 2015
PubMed

Insights

This study explores novel immunotherapies for cervical cancer targeting high-risk human papillomavirus (HPV) E6 and E7 oncogenes. Researchers developed an HPV E7-expressing vaccine and E6/E7 siRNA delivered via polymeric micelles, showing promising anti-tumor effects.

Area of Science:

  • Oncology
  • Immunology
  • Biotechnology

Context:

  • Cervical cancer is frequently driven by high-risk human papillomavirus (HPV) E6 and E7 oncogenes.
  • Targeting these oncogenes presents a promising strategy for cancer immunotherapy.
  • Existing therapies face challenges in effective delivery and immune stimulation.

Purpose:

  • To develop and evaluate novel therapeutic strategies for cervical cancer targeting HPV E6 and E7 oncogenes.
  • To investigate the efficacy of an HPV E7-expressing Lactobacillus casei vaccine for inducing mucosal immunity.
  • To assess the anti-tumor effects of E6/E7 siRNA delivered via PEGylated polymeric micelles for systemic administration.

Summary:

  • A novel therapeutic vaccine, HPV E7-expressing Lactobacillus casei (LacE7), was generated to induce anti-HPV cellular immunity in the intestinal mucosa, with confirmed induction of E7-specific IFNγ-producing cells in cervical lymphocytes.
  • Systemic intravenous administration of HPV16 or 18 E6/E7 siRNA encapsulated in PEGylated polymeric micelles effectively suppressed tumor growth in subcutaneous models using SiHa or HeLa cells, respectively.
  • The study demonstrates the potential of both mucosal vaccination and siRNA delivery systems for cervical cancer treatment.

Impact:

  • This research offers innovative approaches for cervical cancer immunotherapy by leveraging mucosal immunity and advanced drug delivery systems.
  • The findings support the development of targeted therapies against HPV-driven cancers.
  • Successful systemic delivery of siRNA via polymeric micelles opens avenues for treating various cancers requiring targeted gene silencing.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.4K
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.4K

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.4K
Human Virome01:26

Human Virome

The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible...
42
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.5K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K